You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multi Drug-Resistant Tuberculosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multidrug-resistant Tuberculosis

Recruiting
  • Multi-Drug Resistant Tuberculosis
    • Paris, France
      Pitié Salpêtrière Hospital
    Mar 28, 2022

    Pharmacometrics to Advance Novel Regimens for Drug-resistant

    Recruiting
    • Multi-drug Resistant Tuberculosis
      • Almaty, Kazakhstan
      • +6 more
      Nov 1, 2022

      Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

      Active, not recruiting
      • Tuberculosis
      • +4 more
      • Bedaquiline Oral Tablet
      • +7 more
      • Port Elizabeth, Eastern Cape, South Africa
      • +1 more
      Oct 20, 2022

      Multi Drug Resistant Tuberculosis, HIV Trial in Durban (Adherence support intevention)

      Not yet recruiting
      • Multi Drug Resistant Tuberculosis
      • HIV Infections
      • Adherence support intevention
      • Durban, KwaZulu-Natal, South Africa
        King DinuZulu Hospital
      Nov 21, 2022

      Multi-drug Resistant Tuberculosis Trial in China (18-month regimen containing 6 anti-TB drugs)

      Completed
      • Multi-drug Resistant Tuberculosis
      • 18-month regimen containing 6 anti-TB drugs
      • Beijing, China
      • +19 more
      Oct 10, 2022

      Tuberculosis, Multidrug-Resistant Trial in Worldwide (Delamanid, OBR)

      Completed
      Has Results
      • Tuberculosis, Multidrug-Resistant
      • Beijing, China
      • +7 more
      Sep 30, 2021

      Multi-drug Resistant Tuberculosis Trial in Lambarene (Km+ Mfx+ Pto + H + Cfz +E+Z)

      Recruiting
      • Multi-drug Resistant Tuberculosis
      • Km+ Mfx+ Pto + H + Cfz +E+Z
      • Lambarene, Please Select, Gabon
        Centre de Recherches Médicales de Lambaréné
      Jul 26, 2021

      Pulmonary Tuberculosis Trial in Beijing (WX-081, Bedaquiline, Standard treatment)

      Recruiting
      • Pulmonary Tuberculosis
      • Beijing, Beijing, China
        Beijing Chest Hospital affiliated to Capital Medical University
      Dec 14, 2021

      Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,

      Active, not recruiting
      • Tuberculosis, Pulmonary
      • +5 more
      • Tbilisi, Georgia
      • +10 more
      Jan 26, 2022

      Pulmonary Disease, Tuberculosis, Pulmonary, Tuberculosis Trial in San Antonio (TBAJ-876 10mg, TBAJ-876 25mg, TBAJ-876 50mg)

      Active, not recruiting
      • Pulmonary Disease
      • +6 more
      • TBAJ-876 10mg
      • +8 more
      • San Antonio, Texas
        Worldwide Clinical Trials
      Sep 2, 2021

      Vitamin D Status and Adult Multidrug-resistant Pulmonary

      Completed
      • Multi-drug Resistant Tuberculosis
      • Serum Vitamin D
      • Mumbai, Maharashtra, India
        Foundations for Medical Research
      Feb 24, 2021

      Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis Trial in Belarus, South

      Active, not recruiting
      • Multi-drug Resistant Tuberculosis
      • +2 more
      • Minsk, Belarus
      • +4 more
      May 12, 2021

      Tuberculosis, Pulmonary, Tuberculosis, Multidrug Resistant, Extensively Drug-Resistant Tuberculosis Trial in Worldwide

      Completed
      Has Results
      • Tuberculosis, Pulmonary
      • +2 more
      • San Antonio, Texas
      • +16 more
      Nov 1, 2021

      Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculoses Trial in Belarus, South

      Recruiting
      • Multi-drug Resistant Tuberculosis
      • +2 more
      • Minsk, Belarus
      • +6 more
      May 12, 2021

      Pulmonary Tuberculosis Trial in Ysterplaat, Sydenham, Sandringham (Bedaquiline, PA-824, Linezolid)

      Completed
      • Pulmonary Tuberculosis
      • Ysterplaat, Cape Town, South Africa
      • +2 more
      Nov 19, 2020

      Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and

      Not yet recruiting
      • Pulmonary Tuberculosis
      • Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
      • +3 more
      • (no location specified)
      Jul 25, 2023

      Tuberculosis, MDR Trial in Kazakhstan, Kyrgyzstan (FS-1, Placebo)

      Completed
      • Tuberculosis, MDR
      • Semey, East-Kazakhstan Region, Kazakhstan
      • +5 more
      May 17, 2022

      Clinical Evaluation of tNGS for Diagnosis of DR-TB

      Active, not recruiting
      • Tuberculosis, Multidrug-Resistant
      • targeted Next Generation Sequencing (tNGS)
      • Tbilisi, Georgia
      • +2 more
      Jan 23, 2023

      Drug-resistant Tuberculosis, HIV Coinfection, Cost-Benefit Analysis Trial in Cape Town (Targeted next-generation sequencing)

      Not yet recruiting
      • Drug-resistant Tuberculosis
      • +2 more
      • Targeted next-generation sequencing
      • Cape Town, South Africa
        South African National Health Laboratory Service
      Sep 23, 2022

      Tuberculosis, Rifampicin Resistant Tuberculosis Trial in Worldwide (Pretomanid, Optimized background regimen (OBR) for

      Not yet recruiting
      • Tuberculosis
      • Rifampicin Resistant Tuberculosis
      • Pretomanid
      • Optimized background regimen (OBR) for multidrug-resistant TB (MDR-TB
      • Rio De Janeiro, Brazil
      • +6 more
      Oct 18, 2022

      Interferon Gamma Injections in Drug-resistant Pulmonary

      Recruiting
      • Pulmonary Tuberculosis
      • Moscow, Russian Federation
        FSBI "NMIC FPI" of the Ministry of Health of Russia
      May 31, 2022

      Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

      Completed
      • Tuberculosis, Pulmonary
      • +4 more
      • Rio de Janeiro, Brazil
      • +25 more
      Jun 23, 2022

      Risk Factors for Multidrug Resistant Bacteria at ICU Admission

      Not yet recruiting
      • Multi Drug Resistant Bacteria
      • Identification o Multi Drug Resistant Bacteria
      • (no location specified)
      Aug 2, 2023

      Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases

      Not yet recruiting
      • Multi-Drug Resistant Hiv-1 Infection
      • HIV-1 Infection
      • UB-421
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Household Transmission Dynamics of Multidrug Resistant

      Not yet recruiting
      • Adults Patients, With Fecal Carriage of Multi-Drug Resistant Enterobacterales (MDR-E)
        • (no location specified)
        Apr 3, 2023